Due to increased demand, price hikes and long-term shortages, obtaining prescriptions for weight loss drugs such as ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

The U.S. FDA has approved Semaglutide for weight loss and reducing cardiovascular risk in individuals with obesity or overweight and existing cardiovascular conditions. However, the FDA has also ...

It’s sometimes used off-label to support weight loss. The only way to get it is through a prescription from a licensed healthcare professional. Ozempic (semaglutide) is a prescription-only ...

COLUMBUS, Ohio — A survey from The Ohio State University Wexner Medical Center found that a quarter of adults said they’d consider injectable weight loss medication without a doctor consultation ...

Among patients receiving persistent medication at one year, 61% of patients prescribed semaglutide for obesity achieved at ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

It’s a field that’s already undergoing a revolution, with millions of people across the US now using semaglutide and tirzepatide, sold as Wegovy and Zepbound for weight loss (and for diabetes ...